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Abstract
Background
Members of uniformed armed forces are considered to be at high risk for HIV infection and
have been proposed as suitable candidates for participation in HIV intervention studies. We
report on the feasibility of recruitment and follow up of individuals from the community of the
Uganda Police Force (UPF) for an HIV vaccine preparedness study.
Methods
HIV-negative volunteers aged 18–49 years, were identified from UPF facilities situated in
Kampala and Wakiso districts through community HIV counselling and testing. Potential vol-
unteers were referred to the study clinic for screening, enrolment and quarterly visits for one
year. HIV incidence, retention rates were estimated and expressed as cases per 100 person
years of observation (PYO). Rate ratios were used to determine factors associated with
retention using Poisson regression models.
Results
We screened 560 to enroll 500 volunteers between November 2015 and May 2016. One
HIV seroconversion occurred among 431 PYO, for an incidence rate of 0.23/100 PYO (95%
confidence interval [CI]: 0.03–1.64). Overall, retention rate was 87% at one year, and this
was independently associated with residence duration (compared to <1 year, 1 to 5 years
adjusted rate ratio (aRR) = 1.19, 95%CI: 1.00–1.44); and >5 years aRR = 1.34, 95%CI:
0.95–1.37); absence of genital discharge in the last 3 months (aRR = 1.97, 95% CI: 1.38–
2.83, absence of genital ulcers (aRR = 1.90, 95%CI: 1.26–2.87, reporting of new sexual
partner in the last month (aRR = 0.57, 95%CI: 0.45–0.71, being away from home for more
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than two nights (aRR = 1.27, 95%CI: 1.04–1.56, compared to those who had not travelled)
and absence of knowledge on HIV prevention (aRR = 2.67, 95%CI: 1.62–4.39).
Conclusions
While our study demonstrates the feasibility of recruiting and retaining individuals from the
UPF for HIV research, we did observe lower than anticipated HIV incidence, perhaps
because individuals at lower risk of HIV infection may have been the first to come forward to
participate or participants followed HIV risk reduction measures. Our findings suggest les-
sons for recruitment of populations at high risk of HIV infection.
Introduction
The World Health Organization (WHO) identifies uniformed armed personnel among some of
the key populations to be focused upon in the national HIV strategic plans for several countries
in sub-Saharan Africa, due to their higher risk for HIV infection compared to the general popu-
lation [1]. For example, members of the uniformed armed forces in Congo were found to have
higher HIV prevalence compared to the general population (3.8% versus 1.3%) [2]. Similarly,
the Uganda Peoples Defence Forces (UPDF) has been listed among the most at-risk population
due to high HIV incidence rates compared to the general population (3.56 per 100 person-years,
95% confidence interval [CI]: 1.49–5.52, versus 2.1 per 100 person-years, 95%CI: 1.1–3.1) [3, 4].
This is attributed to the nature of their occupation characterised by mobility and long periods of
separation from their families, which predisposes them to risky sexual behaviours [5]. Members
of the Uganda Police Force (UPF) are potentially likely to follow the same trends in HIV risk
since they share similar operational structures as those of the army. A study conducted in Tanza-
nia among members of the urban police force demonstrated high-risk sexual practices including
low condom use, resulting in high HIV prevalence and incidence [6]. Although most of the
countries in sub-Saharan Africa have implemented efforts to address HIV in the armed forces,
there have been gaps noted in the amount of research in this area [7].
Evaluation of novel HIV prevention strategies (including HIV vaccine research) necessitates
the recruitment of populations with presumed high exposure to HIV and high motivation to
remain under study [8]. A study conducted in a population of police officers in Dar-es-Salaam,
Tanzania, demonstrated they were a suitable population for HIV vaccine research due to their
high HIV prevalence and high rate of willingness to participate in future vaccine trials [9].
Thus, the first HIV vaccine trial in Tanzania was conducted in a population of police officers
[10]. There is surprisingly little reliable data on the prevalence and incidence of HIV among
other uniformed personnel in East Africa, including the UPF, and their suitability as potential
participants of HIV vaccine trials. In this paper, we describe the findings of a study to deter-
mine the acceptability and suitability of UPF personnel for future HIV vaccine trials by setting
up a cohort study to estimate the recruitment and retention rates as well as HIV incidence rate
and associated factors over a one-year period.
Methods
Study settings
The study was conducted in a population of individuals living within police barracks commu-
nities of the Uganda Police, all situated within the Kampala and surrounding Wakiso districts.
These communities were chosen because they have the highest number of residents and were
thought to have a good representation of the various police departments. All potential and
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interested volunteers from each of these communities were referred to a centrally located
study clinic based at a central Kampala police barracks (one of the largest in East Africa)
maternity clinic for screening, enrolment and follow-up. The clinic offers services to both
police and non-police individuals living within its catchment area.
Volunteer identification and screening
The team of study community field workers comprising of trained counsellors and mobilisers
together with peer UPF community members, moved from door to door inviting volunteers
from the barracks population to attend a pre-screening involving free community voluntary
HIV counselling and testing regardless of whether they were police officers or not, as long as
they were barracks residents. Our study population was ultimately composed of police officers
from various police departments and other civilians (usually relatives of police officers) living
within the different facilities. Volunteers aged 18 to 49 years who were found to be HIV-nega-
tive were given brief information about the study and asked if they were willing to enrol in the
cohort requiring quarterly visits for up to one year, and given a referral note to the study clinic
for enrolment. Those found to be HIV-positive on rapid testing in the community had a
serum sample sent for HIV confirmatory ELISA testing at the MRC/UVRI & LSHTM labora-
tory in Entebbe. The confirmed HIV-positive individuals received their results within two
weeks and were referred to specified HIV treatment and care centres.
At the research clinic, HIV-negative volunteers received detailed group information about
the study, followed by one to one sessions where they were allowed to ask further questions
about the study. The remaining volunteers provided written informed consent for the screen-
ing and enrolment procedures, which consisted of an HIV risk assessment, a baseline medical
history, followed by full physical examination including a genital examination, a confirmatory
repeat HIV rapid test and a serum sample collection for syphilis testing and storage, and preg-
nancy testing for women.
Volunteers who fulfilled the inclusion criteria: (i) aged 18–49 years, (ii) being sexually active
in the past three months, (iii) willing to attend study visits and procedures, and (iv) reported to
be at high-risk for HIV in the last three months (defined by: experienced a sexually transmitted
infection (STI) episode/ engaged in condomless sex with new or more than one sexual partner/
reported alcohol consumption at least 3 times a week) were then invited to the study proce-
dures. Those enrolled provided demographic information including duration of residence in
the community, locator information on how they could be traced; they were treated for any
medical conditions including sexually transmitted infections (STI) that had been reported or
diagnosed (clinically or laboratory); they were reimbursed for transport and time spent at the
clinic (approximately US$ 3); and they received an appointment card for follow-up visits. Vol-
unteers who were found not eligible but required treatment were offered referrals to appropri-
ate facilities.
Follow-up procedures
A study clerk made a reminder phone call one week before the participant’s scheduled follow-
up visit date. All study follow-up visit procedures were conducted at the same study clinic. At
each quarterly follow-up visit, participants received HIV counselling and testing followed by a
symptom-directed physical examination, pregnancy testing (females) and syndromic manage-
ment of STIs if required. Participants who tested positive for HIV were referred to convenient
HIV treatment and care centres. In-depth interviews on HIV risk were conducted in months 6
and 12 during study visits. Willingness to participate in future HIV vaccine trials was assessed
at months 9 and 12. At month 12, participants received repeat testing for syphilis (as well as
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HIV). At the end of each study visit the participant’s locator/contact data were updated and
participants were reimbursed for transport and time spent at the clinic. Participants who
missed their appointment date were given reminder calls and informed to come within a visit
window of 7 days. At the study clinic, study counsellors offered continuous free HIV counsel-
ling and testing to anyone in the community throughout the entire study period.
Laboratory testing
Each participant provided 5ml blood serum at each visit. HIV testing was done based on the
MRC/UVRI & LSHTM standardised HIV testing algorithm at both screening and follow-up
visits using the Alere Determine Rapid test (Alere Medical Co Ltd. Chiba, Japan), and if posi-
tive, an aliquot form the serum sample collected the same date was taken to the central labora-
tory at MRC/UVRI & LSHTM in Entebbe for confirmation using two serial ELISA tests
(Murex HIV-1.2.0 Ab, Diasorin UK, followed by Bioelisa Ag+Ab, Biokit, Spain). Syphilis ser-
ostatus was determined using the Treponema Pallidum Haemagglutination Assay (TPHA, Ser-
odia-TP.PA, Fujirebio Inc, Japan) confirmed with Rapid Plasma Reagin (RPR, BD Macro-
Vue, Becton Dickson & Co, USA). All TPHA positive cases confirmed with a RPR titre greater
than 1:8 were considered ‘high titre active syphilis’ cases and treatment given. Urine pregnancy
testing was performed using QuickVue (Quidel Corporation, USA).
Statistical analysis
Data were captured in MS Access, 2003 (Microsoft Corporation, Redmond, WA), and ana-
lysed in Stata 15.0 (Stata Corp, College station, TX, USA). Descriptive baseline characteristics
were stratified by gender. Self-reported risk behaviours and clinician-observed characteristics
were summarised by months of follow-up and compared using Chi-square or Fisher’s Exact
tests. The retention rate was estimated as the number of participants retained at the final visit
(month 12) divided by the number of person-years of observation (PYO), expressed as a rate
per 100 PYO. PYO were estimated as the difference in the dates between enrolment and last
date seen at the clinic or date of HIV infection. Rate ratios and their 95% confidence intervals
(CI) were used to determine factors associated with retention in univariate and multivariable
analyses using Poisson regression models. Participants’ time-changing variables were treated
as such in the Poisson models, allowing for intragroup correlation by use of robust standard
errors since volunteers had multiple observations. In the multivariable Poisson regression
models, we retained only those factors that caused a change in the rate of>20%, except for sex
and age group that were included a priori.
Ethical considerations
The study received approval from the clinic institutional review board, the Uganda Virus
Research Institute Research Ethics Committee (UVRI-REC) and the Uganda National Council
for Science and Technology (UNCST). Each volunteer gave written informed consent before
enrolment into the study. Individuals found to be HIV-positive were referred to appropriate treat-
ment services, including antenatal clinics providing PMTCT, and those found to have high-titre
syphilis were treated according to national guidelines at the referral clinic.
Results
Baseline characteristics
Between November 2015 and May 2016, the study team screened 560 individuals (67% males)
and enrolled 500 (69% males) volunteers. Reasons for non-enrolment are presented in Fig 1,
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Fig 1. The UPF study cohort profile.
https://doi.org/10.1371/journal.pone.0231640.g001
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mostly because of estimated low HIV risk. Most participants were aged 25–34 years, had sec-
ondary education or more, were married, and had lived in the barracks for a period of 1 to 5
years (Table 1).
HIV incidence, syphilis prevalence and incidence, and trends in reported
sexual risk behavior and HIV prevention knowledge
Volunteers were followed-up for one year with the last visit occurring in May 2017. During fol-
low-up we observed only one HIV seroconversion in 431 PYO, translating into an HIV inci-
dence rate (IR) of 0.23/100 PYO (95%CI: 0.03–1.64). There were 4 cases of confirmed syphilis
among the 500 recruited volunteers, a baseline prevalence of 0.8% (95%CI: 0.22–2.04), whilst 6
new cases of syphilis (TPHA+/RPR >1:8) were observed during follow up in 432 PYO, trans-
lating into a syphilis IR of 1.4/100 PYO (95%CI: 0.62–3.09). During follow up 31 new pregnan-
cies were observed among the participating females over 133.7 years of follow-up resulting
into a pregnancy IR of 23.19/100 PYO (95%CI: 16.31–32.97).
Over the follow-up period there was a significant reduction in the proportion of volunteers
reporting high-risk behaviors, in both males and females. Amongst male volunteers there was a
significant reduction in: self-reported STIs, alcohol consumption, reporting 3 or more sexual
partners over the last 3 months, never using a condom with new sexual partner, travelling away
from home, not practicing any HIV prevention methods. However, there were no changes in
the knowledge of HIV prevention methods and male circumcision status in the cohort. For the
female volunteers, there was an observed significant reduction in the reported genital ulcers
and discharge, multiple partners and not practicing any HIV prevention methods. There was
no observed trend in: the use of alcohol (which remained low throughout the period of follow-
up compared to men), condom use with a new sexual partner, knowledge of HIV prevention
and travelling away from home (see Table 2).
Table 1. Baseline characteristics of individuals recruited in the Uganda Police Force HIV vaccine preparedness study.
Characteristic Category Males (N = 345) n (%) Females (N = 155) n (%)
Age group, years 18–24 81 (23.5) 53 (34.2)
25–34 154 (44.6) 75 (48.4)
35+ 110 (31.9) 27 (17.4)
Education Primary 19 (5.5) 39 (25.2)
Secondary 248 (71.9) 80 (51.6)
Tertiary 78 (22.6) 36 (23.2)
Religion Anglican 141 (40.9) 62 (40.0)
Catholic 149 (43.2) 51 (32.9)
Muslim 30 (8.7) 20 (12.9)
Pentecostal 15 (4.3) 13 (8.4)
Other 10 (2.9) 9 (5.8)
Marital status Single (never married) 107 (31.0) 42 (27.1)
Married (one wife/husband) 160 (46.4) 76 (49.0)
Married (polygamous) 42 (12.1) 7 (4.5)
Cohabiting 32 (9.3) 27 (17.4)
Widowed/Separated 4 (1.2) 3 (2.0)
Residence duration < 1 year 73 (21.1) 19 (12.3)
1–5 years 180 (52.2) 73 (47.1)
>5 years 92 (26.7) 63 (40.6)
https://doi.org/10.1371/journal.pone.0231640.t001
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Table 2. Risk behavior at enrolment/month 0, month 6, and month 12, by sex.
Risk behavior Males Females
Month 0 Month 6 Month 12 p-value Month 0 Month 6 Month 12 p-value
Observed by clinician at examination
Genital discharge disease
Yes 33 (9.6) 12 (3.9) 5 (2.0) <0.01 109 (70.3) 31 (22.3) 15 (13.8) <0.001
No 312 (90.4) 294 (96.1) 252 (98.0) 46 (29.7) 108 (77.7) 94 (86.2)
Genital ulcers
Yes 62 (18.0) 15 (4.9) 5 (2.0) <0.01 92 (59.4) 18 (12.9) 7 (6.4) <0.001
No 283 (82.0) 293 (95.1) 250 (98.0) 63 (40.6) 122 (87.1) 102 (93.6)
Circumcision status
Circumcised 246 (72.6) 223 (72.6) 193 (75.1) 0.746 N/A N/A N/A
Not Circumcised 93 (27.4) 84 (27.4) 64 (24.9) N/A N/A N/A
Self-report
Alcohol consumption
None 134 (38.8) 148 (47.9) 141 (54.6) <0.01 125 (80.6) 119 (85.0) 89 (82.4) 0.862�
Weekly 131 (38.0) 86 (27.8) 59 (22.9) 8 (5.2) 7 (5.0) 6 (5.6)
1–3 times/month 57 (16.5) 62 (20.1) 48 (18.6) 20 (12.9) 14 (10.0) 13 (12.0)
Daily 23 (6.7) 13 (4.2) 10 (3.9) 2 (1.3) 0 (0.0) 0 (0.0)
Having sex while drunk (among those reporting drinking)
Never 66 (31.4) 73 (46.2) 42 (36.2) 0.034� 13 (43.3) 12 (57.1) 11 (52.4) 0.811�
Sometimes 113 (53.8) 69 (43.7) 67 (57.8) 14 (46.7) 7 (33.3) 10 (47.6)
Frequently 21 (10.0) 11 (7.0) 5 (5.3) 2 (6.7) 1 (4.8) 0 (0.0)
Always 10 (4.8) 5 (3.1) 2 (1.7) 1 (3.3) 1 (4.8) 0 (0.0)
Number of sexual partners
0/1 115 (33.4) 198 (65.8) 171 (67.3) <0.01 129 (83.2) 134 (95.7) 105 (97.2) <0.001�
2 160 (46.5) 68 (22.6) 65 (25.6) 23 (14.8) 6 (4.3) 3 (2.8)
3+ 69 (20.1) 35 (11.6) 18 (7.1) 3 (1.9) 0 (0.0) 0 (0.0)
Having a new sexual partner
No 158 (46.2) 206 (76.6) 183 (82.8) <0.01 114 (78.1) 122 (96.8) 88 (97.8) <0.001�
Yes 184 (53.8) 63 (23.4) 38 (17.2) 32 (21.9) 4 (3.2) 2 (2.2)
Condom use with new partner
Never 104 (56.5) 19 (30.2) 26 (26.3) <0.01� 15 (46.9) 2 (50.0) 1 (50.0) 0.941�
Sometimes 40 (21.7) 14 (22.2) 4 (10.5) 10 (31.3) 1 (25.0) 0 (0.0)
Frequently 9 (4.9) 2 (3.2) 2 (5.3) 0 (0.0) 0 (0.0) 0 (0.0)
Always 31 (16.9) 28 (44.4) 22 (57.9) 7 (21.9) 1 (25.0) 1 (50.0)
Know any HIV prevention methods
Yes 344 (99.7) 306 (99.0) 252 (97.7) 0.058� 153 (99.4) 140 (100) 106 (97.3) 0.097�
No 1 (0.3) 3 (1.0) 6 (2.3) 1 (0.6) 0 (0.0) 3 (2.7)
Practice any HIV prevention method
Yes 295 (85.8) 295 (96.4) 231 (91.7) <0.01 142 (92.8) 140 (100) 104 (98.1) 0.001�
No 49 (14.2) 11 (3.6) 21 (8.3) 11 (7.2) 0 (0.0) 2 (1.9)
HIV prevention methods practiced
Condom 187 (63.4) 111 (37.4) 73 (30.8) <0.01� 20 (14.1) 13 (9.3) 7 (6.5) 0.003�
Being Faithful 82 (27.8) 157 (52.8) 146 (61.6) 111 (78.2) 121 (86.4) 90 (84.1)
Abstinence 16 (5.4) 19 (6.4) 18 (7.6) 4 (2.8) 6 (4.3) 10 (9.4)
Other 10 (3.4) 10 (3.4) 0 (0.0) 7 (4.9) 0 (0.0) 0 (0.0)
Travelling
Yes 259 (76.2) 199 (64.6) 146 (56.8) <0.01 42 (29.0) 32 (22.9) 24 (22.0) 0.354
(Continued)
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Retention and associated factors
Over the period of follow up, 376 volunteers completed their final follow-up, occurring over
a period of 432 PYO, resulting in an overall retention rate of 87% (Table 3). In the adjusted
model, retention at one year was significantly associated with the following baseline charac-
teristics: residence duration (higher among those who had resided for 1 to 5 years (adjusted
rate ratio [aRR] = 1.19, 95%CI: 1.00–1.44) or had spent more than 5 years (aRR = 1.34, 95%
CI: 0.95–1.37) compared to those who had resided for less than a year); absence of genital
discharge in the last 3 months (higher among those who reported no genital discharge
(aRR = 1.97, 95%CI: 1.38–2.83) compared to those reporting genital discharge); absence of
genital ulcers in the last 3 months (higher among those reporting no ulcers (aRR = 1.90, 95%
CI: 1.26–2.87) compared to those reporting ulcers); alcohol consumption in the last month
(lower retention among those reporting daily consumption (aRR = 0.68, 95% CI: 0.41–1.11)
compared to those who had not drank alcohol); report of a new sexual partner in the last
month (lower in those reporting new partner (aRR = 0.57, 95%CI: 0.45–0.71) compared to
those reporting no new partner), time away from home, higher among those away for more
than two nights (aRR = 1.27, 95%CI: 1.04–1.56) compared to those who had no overnight
trips in the preceding period) and absence of knowledge on HIV prevention (aRR = 2.67,
95%CI: 1.62–4.39) compared to those who reported knowledge(Table 3).
Discussion
Our study shows that it is feasible to recruit and adequately follow up volunteers from a popu-
lation composed of police force and their relatives for research. We established incidence rates
of HIV and syphilis in this population. However, the data show an unexpectedly low HIV inci-
dence and low syphilis prevalence which might be as a result of our recruitment methods. Dur-
ing recruitment some individuals at high risk of infection were selected out at screening and
lost to follow up. The heterogeneous composition of our cohort, including non-police officers
could have caused some form of risk dilution by including low risk individuals explaining the
low incidence if HIV despite high rates of condomless sex as evidenced, for women, by the
high pregnancy rates. Of the 2059 individuals who attended the community voluntary HIV
testing, only 560 (27.2%) made it to the clinic for further study eligibility assessment. This was
because majority of those approached only required HIV testing services and although the
study sample size of 500 was attained, the testing service continued.
The observed low incidence of HIV and syphilis is encouraging and may be partly due
to the education level and prior HIV/STI -prevention knowledge of those recruited into
the cohort. In addition, HIV testing is mandatory for recruitment into the police force in
Uganda, and only HIV negative individuals are eligible to stay, this is likely to have contrib-
uted to the low prevalence and incidence because we had a number of newly recruited mem-
bers of the force in the cohort. Of note, the low HIV incidence would make this population
suitable for phase I and II trials which require low risk individuals for safety and immunoge-
nicity studies [11].
Table 2. (Continued)
Risk behavior Males Females
Month 0 Month 6 Month 12 p-value Month 0 Month 6 Month 12 p-value
No 81 (23.8) 109 (35.4) 111 (43.2) 103 (71.0) 108 (77.1) 85 (78.0)
�Fisher’s Exact p-value
https://doi.org/10.1371/journal.pone.0231640.t002
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Table 3. Univariate and multivariable analyses of factors associated with one-year retention in a cohort of Uganda Police Force community in Kampala and Wakiso
Districts, Uganda.
Variable Attended PYO Rate RR (95%CI) LRT P-value aRR (95%CI)
Overall 1 year retention 376 432.1 87.0
Gender
Male 261 296.9 87.9 1 0.506 1
Female 115 135.2 85.1 0.97 (0.88–1.07) 0.87 (0.75–1.01)
Age, years
18–24 96 114.3 84.0 1 0.472 1
25–34 173 199.2 86.8 1.03 (0.92–1.16) 1.06 (0.92–1.23)
35+ 107 118.2 90.3 1.08 (0.95–1.21) 1.14 (0.98–1.33)
Religion
Muslim 29 38.8 74.8 1 <0.001
Catholic 154 175.6 87.7 1.17 (0.95–1.45)
Anglican 155 175.7 88.2 1.18 (0.96–1.45)
Pentecostal 20 25.5 78.5 1.05 (0.77–1.43)
Other (Seventh day Adventist) 18 16.5 100 1.46 (1.20–1.78)
Education level
Primary 43 52.0 82.7 1 0.768
Secondary 244 161.6 87.6 1.06 (0.91–1.24)
Tertiary 89 101.6 87.6 1.06 (0.89–1.26)
Marital status
Single 214 244.8 87.4 1 0.963
Married 51 58.5 87.1 0.99 (0.87–1.14)
Widowed/Separated 111 128.7 86.2 0.99 (0.89–1.09)
Duration of residence
Under 1 year 59 79.1 74.6 1 0.050 1
1 to 5 years 195 216.3 90.2 1.21 (1.04–1.41) 1.19 (1.00–1.44)
> 5 years 122 136.8 89.2 1.20 (1.02–1.40) 1.34 (0.95–1.37)
Genital discharge, last three months
Yes 25 59.3 42.2 1 <0.001 1
No 351 372.8 94.1 2.23 (1.60–3.11) 1.97 (1.38–2.83)
Genital ulcers, last three months
Yes 21 55.8 37.6 1 <0.001 1
No 355 376.3 94.4 2.51 (1.72–3.66) 1.90 (1.26–2.87)
Circumcision (males only)
Yes 199 216.5 91.9 1 0.091
No 62 78.8 78.6 0.86 (0.71–1.03)
If not, do you intend to get circumcised (males only)
Yes 75 65.2 100 1 0.001
No 8 15.6 51.5 0.45 (0.25–0.81)
Not sure 6 12.8 46.8 0.41 (0.20–0.81)
Drank alcohol, last month
None 236 249.0 94.8 1 0.007 1
1–3 times a month 60 72.0 83.3 0.88 (0.71–1.09) 0.92 (0.73–1.15)
Weekly 70 97.1 72.1 0.76 (0.64–0.91) 0.74 (0.61–0.91)
Daily 10 14.0 71.5 0.75 (0.471.20) 0.68 (0.41–1.11)
Alcohol consumption before sex, last month
Never 144 156.2 92.2 1 0.280
(Continued)
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The observed decline in the reported risk behaviours over one year could be attributed to
the risk reduction counselling that was offered at each quarterly visit. A similar finding was
observed in a female sex worker cohort study, by Traore et al. [12] in Burkina Faso, where zero
HIV infections were observed following a combination intervention over a two year period. In
another study conducted by Kaul et al. [13] among female sex workers in Nairobi, a reduction
in risk taking was observed after an intensive period of risk reduction counselling and regular
STI treatment. In another study, Ghys et al. [14] found that HIV prevention intervention con-
tributed to significant lowering of the HIV-1 seroincidence rate during the intervention study
than before the study (6.5 versus 16.3 per 100 person-years; P = 0.02). However, such a reduc-
tion as observed in our study should be interpreted with caution, since it could also be a result
of social desirability bias [15, 16].
Our study demonstrated a good overall retention rate in this population. In common with
similar studies [17], we observed that retention was better among volunteers who had lived in
the facility longer, a possible reflection of their relative stability, which may also have affected
their HIV-infection risk. Volunteers who reported no knowledge of HIV risk were more likely
to be retained compared to those reporting to be knowledgeable, possibly because the latter
Table 3. (Continued)
Variable Attended PYO Rate RR (95%CI) LRT P-value aRR (95%CI)
Sometimes < than half the time 193 224.0 86.2 0.93 (0.81–1.07)
Frequently > than half the time 28 35.3 79.3 0.86 (0.67–1.11)
Always 11 16.7 66.1 0.72 (0.47–1.10)
Number of sexual partners, last month
0–1 284 295.9 95.9 1 0.001 1
2 73 96.2 75.8 0.79 (0.65–0.97) 0.90 (0.73–1.12)
3 19 39.8 47.7 0.50 (0.34–0.73) 0.74 (0.48–1.12)
New sexual partner, last 3 months
No 317 318.8 99.4 1 <0.001 1
Yes 59 113.2 52.1 0.52 (0.42–0.65) 0.57 (0.45–0.71)
Condom with new partner, last 3 months
Never 10 7.5 100 1 0.296
Sometimes < than half the time 3 5.4 56.0 0.42 (0.13–1.35)
Frequently > than half the time 2 0.9 100 1.67 (0.59–4.68)
Always 20 13.2 100 1.14 (0.66–1.95)
Away from home� 2 nights, last 3 months
Yes 181 235.1 77.0 1 0.003 1
No 195 197.0 99.0 1.29 (1.09–1.52) 1.27 (1.04–1.56)
Do you know any HIV prevention method
Yes 367 427.4 85.9 1 0.017 1
No 9 4.7 100 2.45 (1.16–4.35) 2.67 (1.62–4.39)
Do you practice any HIV prevention method
Yes 355 404.7 87.0 1 0.499
No 21 27.3 76.9 0.88 (0.60–1.28)
If yes, current prevention practices
Abstinence 24 24.7 97.3 1 <0.001
Being faithful to my partner 257 243.2 100 1.09 (0.77–1.53)
Condom 86 136.3 63.1 0.65 (0.44–0.95)
Other 7 10.1 69.3 0.71 (0.40–1.27)
https://doi.org/10.1371/journal.pone.0231640.t003
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sought to attend in order to acquire more knowledge. We observed that loss to follow up was
associated with volunteers who reported the most high-risk behaviours as well as those who
reported having travelled away from home in the last month. This association may also explain
the low incidence observed in the study.
Our study had limitations. Firstly, during screening and recruitment of our study popula-
tion, we did not systematically recruit to ensure a weighted representation from the different
police departments and ranks, giving rise to possible selection bias. From our anecdotal obser-
vations, we noted that the majority of enrolled police officers were from lower ranks, and we
had no representation from some of the departments such as the traffic and mobile patrol
units, who might differ in terms of the variables and outcomes we were investigating. Sec-
ondly, our study was not designed to collect specific reasons why volunteers were lost to follow
up, which would be useful in explaining the reasons and so inform possible interventions.
Thirdly, the study findings are based mostly on self-report which might potentially introduce
social desirability bias if participants choose to modify their responses to mask risk behaviour.
However, inclusion of biological information such as HIV and syphilis incidence add credence
to our findings.
Conclusions
The study showed it is possible to recruit and adequately follow up volunteers from the com-
munity of the Uganda Police Force for participation in future HIV vaccine trials. The low HIV
incidence and decline in HIV risk behaviour during follow-up, combined with the favourable
retention rate could make this population potentially suitable for Phase I & II HIV vaccine tri-
als, where low risk individuals are required. However, the surprisingly low HIV incidence in
our cohort suggests that those at higher risk of infection (i.e., those in mobile divisions in the
force) may have been omitted from our cohort, and such population would not be adequate
for Phase III HIV vaccine trials. We recommend more stringent sampling to ensure greater
representation of different ranks and divisions (i.e. traffic police) in future epidemiological
studies in such similar populations.
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